FDA Approves Tivicay for HIV Infection
The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat...
Read More
Author: PWeekly
Review: interventions to increase influenza vaccination among healthcare workers in hospitals
Abstract Annual influenza vaccination rates among hospital healthcare workers (HCW) are almost...
Read More
FDA Approves Gilotrif for Late-Stage NSCLC
The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late...
Read More
IAS 2013: Positive Outcomes With HIV Prevention Program
The Particulars: Previous studies have not compared the effects of mobile HIV testing, community...
Read More
IAS 2013: Repeat Use of Post-Exposure HIV Prophylaxis
The Particulars: Anecdotal evidence suggests that post-exposure prophylaxis for HIV—meant to be a...
Read More
IAS 2013: HCV Reinfection High Among Gay Men With HIV
The Particulars: Liver disease—often due to co-infection with hepatitis c virus (HCV)...
Read More
IAS 2013: CD4 Count Linked With HIV Reservoir Level
The Particulars: Research suggests that patients who start HIV treatment with a CD4 count above...
Read More
ISA 2013: HIV Patients Have High ESRD Rate
The Particulars: Previous studies indicate that some of the same risk factors are associated with...
Read More
ASE 2013: Fetal Echocardiography in Early Pregnancy
The Particulars: Screening mothers during their first trimester enables clinicians to detect if...
Read More
ASE 2013: Valve Replacement – Risk Factors for PPM
The Particulars: Prosthesis-patient mismatch (PPM) appears to affect survival, according to...
Read More
ASE 2013: Predicting CHF Readmissions
The Particulars: Research indicates that congestive heart failure (CHF) is associated with high...
Read More
ASE 2013: Outcomes of Infants with Hypoplastic Left Heart Syndrome
Minneapolis, MN: Researchers have announced the results of a retrospective 5-year study, which...
Read More
ASE 2013: New Correlation for Increased Mortality Associated with TAVR
Minneapolis, MN: Researchers have announced the results of a study which shows a key difference in...
Read More
Brisdelle – First Non-hormonal Treatment for Hot Flashes Associated With Menopause
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine)to treat moderate to...
Read More
ADA 2013: Mixed Results With Lifestyle Intervention for Obese Diabetics
The Particulars: The effects of long-term, intensive lifestyle interventions focused on weight...
Read More
ADA 2013: Achieving Lifestyle Changes in the Unmotivated
The Particulars: Previous studies indicate that increased exercise and healthy diet can help...
Read More
ADA 2013: Wide-Ranging Benefits of Intensive Type 1 Diabetes Therapy
The Particulars: The Epidemiology of Diabetes Interventions and Complications (EDIC) study was...
Read More
ADA 2013: Major Advance Toward an Artificial Pancreas
“Smart” Device That Reduces Low Blood Glucose Levels Overnight Undergoing FDA Review. Chicago...
Read More
ADA 2013: Training Fat to Be Good
The Particulars: The effects of exercise on those who do not lose weight have not been well...
Read More